Novel multimodal analgesic regimen for perioperative pain management after hepatic artery infusion chemotherapy in patients with advanced hepatocellular carcinoma

doi:10.4240/wjgs.v17.i4.101439

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 4

This Article

(108)

(0)

(8)

(2651)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastrointest Surg. Apr 27, 2025; 17(4): 101439
Published online Apr 27, 2025. doi: 10.4240/wjgs.v17.i4.101439

Full Size Figure Download Figure

Figure 1 Flowchart exhibiting course of the study. HAIC: Hepatic artery infusion chemotherapy; PCA: Patient-controlled analgesia; VAS: Visual analog scale.

Citation: Yan J, An R, Wang JJ, Wang M, Zhao Q, Zhao S, Xu J. Novel multimodal analgesic regimen for perioperative pain management after hepatic artery infusion chemotherapy in patients with advanced hepatocellular carcinoma. World J Gastrointest Surg 2025; 17(4): 101439
URL: https://www.wjgnet.com/1948-9366/full/v17/i4/101439.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i4.101439

Yan J, An R, Wang JJ, Wang M, Zhao Q, Zhao S, Xu J. Novel multimodal analgesic regimen for perioperative pain management after hepatic artery infusion chemotherapy in patients with advanced hepatocellular carcinoma. World J Gastrointest Surg 2025; 17(4): 101439 [PMID: 40291897 DOI: 10.4240/wjgs.v17.i4.101439]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.